Allocation of authorship and patient enrollment among global clinical trials in oncology
Cancer · 15.09.2023 · 129 (18) · 2856-2863
DOI: 10.1002/cncr.34919 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, online erschienen am 29.06.2023. Verfasst von Fidel Rubagumya und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada. Hauptthemen laut MEDLINE: Authorship, Developing Countries. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Oncology randomized controlled trials (RCTs) are increasingly global in scope. Whether authorship is equitably shared between investigators from high‐income countries (HIC) and low‐middle/upper‐middle incomes countries (LMIC/UMIC) is not well described. The authors conducted this study to understand the allocation of authorship and patient enrollment across all oncology RCTs conducted globally.
Methods
A cross‐sectional retrospective cohort study of phase 3 RCTs (published 2014–2017) that were led by investigators in HIC and recruited patients in LMIC/UMIC.
Findings
During 2014–2017, 694 oncology RCTs were published; 636 (92%) were led by investigators from HIC. Among these HIC‐led trials, 186 (29%) enrolled patients in LMIC/UMIC. One‐third (33%, 62 of 186) of RCTs had no authors from LMIC/UMIC. Forty percent (74 of 186) of RCTs reported patient enrollment by country; in 50% (37 of 74) of these trials, LMIC/UMIC contributed
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada.
- Department of Oncology, Queen's University, Kingston, Ontario, Canada.
- Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
- Department of Oncology, Rwanda Military Hospital, Kigali, Rwanda.
- British Columbia Cancer Agency, Victoria, British Columbia, Canada.
- American University of Beirut Medical Center, Beirut, Lebanon.
ORCID-Profile: Fidel Rubagumya, Alexandru Eniu, Christopher M Booth
Zitieren
APA
Rubagumya, F., Fundytus, A., Keith-Brown, S., Hopman, W. M., Gyawali, B., Mukherji, D., Hammad, N., Pramesh, C. S., Aggarwal, A., Eniu, A., Sengar, M., Riechelmann, R. S. R., Sullivan, R., & Booth, C. M. (2023). Allocation of authorship and patient enrollment among global clinical trials in oncology. Cancer, 129(18), 2856-2863. https://doi.org/10.1002/cncr.34919
Vancouver
Rubagumya F, Fundytus A, Keith-Brown S, Hopman WM, Gyawali B, Mukherji D, et al. Allocation of authorship and patient enrollment among global clinical trials in oncology. Cancer. 2023;129(18):2856-2863. doi:10.1002/cncr.34919
BibTeX
@article{Rubagumya2023,
author = {Rubagumya, Fidel and Fundytus, Adam and Keith-Brown, Sophie and Hopman, Wilma M and Gyawali, Bishal and Mukherji, Deborah and Hammad, Nazik and Pramesh, C S and Aggarwal, Ajay and Eniu, Alexandru and Sengar, Manju and Riechelmann, Rachel S R and Sullivan, Richard and Booth, Christopher M},
title = {Allocation of authorship and patient enrollment among global clinical trials in oncology},
journal = {Cancer},
year = {2023},
volume = {129},
number = {18},
pages = {2856--2863},
doi = {10.1002/cncr.34919}
}
EUVIMED